IP Library Granted Patent US 7,164,942
Granted Patent B2
US 7,164,942 · App. 10/775,725 · Granted Jan 16, 2007

Handheld apparatus and method for transdermal drug delivery and analyte extraction

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,164,942
App. No.
10/775,725
Granted
Jan 16, 2007
Kind
B2
Abstract

A device is provided for treating skin on the body of a subject. The device includes a plurality of electrodes, which are adapted to be placed in contact with the skin and then moved across the skin while maintaining electrical contact with the skin. The device additionally includes a power source, which is adapted to apply a current between two or more of the plurality of electrodes at the same time as the electrodes are being moved across the skin.

Claims (18)

1. A device for ablating stratum corneum epidermidis of skin on the body of a subject, comprising:

a plurality of electrodes, which are adapted to be applied to the skin of the subject at respective points; and

a power source, which is adapted to apply electrical energy between two or more of the plurality of electrodes, to cause ablation of an area of the stratum corneum during a first time period, so as to facilitate passage of a substance through the ablated area into the body during a second time period, subsequent to the first time period,

wherein the power source is adapted to apply the electrical energy as alternating current,

wherein the plurality of electrodes comprise a common electrode and a plurality of positive electrodes, and

wherein the power source is configured such that, during a phase of the alternating current, the alternating current from the power source flows from each positive electrode, through the skin, to the common electrode.

2. A device for ablating stratum corneum epidermidis of skin on the body of a subject, comprising:

a plurality of electrodes, which are adapted to be applied to the skin of the subject at respective points;

a power source, which is adapted to apply electrical energy between two or more of the plurality of electrodes, to cause ablation of an area of the stratum corneum during a first time period, so as to facilitate passage of a substance through the ablated area during a second time period, subsequent to the first time period; and

a plurality of resistors, coupled to the plurality of electrodes.

3. The device according to claim 2 , wherein each resistor is coupled to a respective one of the plurality of electrodes.

4. The device according to claim 2 , wherein the power source is adapted to drive the current from a first one of the electrodes, through the stratum corneum, to a plurality of other ones of the electrodes.

5. The device according to claim 2 , wherein the power source is adapted to apply the electrical energy as alternating current.

6. A device for ablating stratum corneum epidermidis of skin on the body of a subject, comprising:

a plurality of electrodes, which are adapted to be applied to the skin of the subject at respective points; and

a power source, which is adapted to apply electrical energy between two or more of the plurality of electrodes, to cause ablation of an area of the stratum corneum during a first time period, so as to facilitate passage of a substance through the ablated area into the body during a second time period, subsequent to the first time period,

wherein the two or more of the plurality of electrodes comprise: (a) a plurality of current-driving electrodes, and (b) a plurality of return electrodes, and

wherein, in applying the electrical energy, the power source is adapted to drive current from the current-driving electrodes, through the stratum corneum, to the plurality of return electrodes.

Assignments (4)
RELEASE (REEL 043925 / FRAME 0001) Recorded Apr 4, 2022
From: ING CAPITAL LLC
To: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
Reel/Frame 059593/0131 →
SECURITY AGREEMENT Recorded Sep 20, 2017
From: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
To: ING CAPITAL LLC, AS COLLATERAL AGENT
Reel/Frame 043925/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2012
From: TRANSPHARMA MEDICAL LTD
To: SYNERON MEDICAL LTD
Reel/Frame 028108/0010 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2012
From: AVRAHAMI, ZOHAR; SOHN, ZE'EV
To: TRANSPHARMA MEDICAL LTD.
Reel/Frame 027962/0467 →